News

Technological advances empower the modification of NK cells and renewed potential for therapeutic uses in cancer and ...
To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...
A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...
A supplemental Biologics License Application has been submitted to the FDA for Anktiva plus BCG in papillary NMIBC.
Get Instant Summarized Text (Gist) Genetically modified natural killer (NK) cells have shown potential in cancer immunotherapy by overcoming tumor defenses. Using CRISPR/Cas9, researchers ...
A multinational research team of clinicians and scientists from South Korea and Singapore has published positive findings ...
When your body senses something is wrong—whether it's a damaged cell or a growing tumor—it can react in many ways. One of the ...
With groundbreaking innovations in vaccines and immunotherapy, Medigen Biomedical Group is revolutionizing healthcare, and ...
Converging computational and laboratory technologies are helping anti-cancer immune responses hit their target more ...
Among other functions, the NK cells (Natural Killers, a type of lymphocyte forming part of the immune system) have the capacity to detect and eliminate cancer cells. But in some cases they cannot ...